Lexeo Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Townsend Richard Nolan unloaded Company’s shares for reported $19557.0 on Nov 11 ’24. In the deal valued at $7.82 per share,2,500 shares were sold. As a result of this transaction, Townsend Richard Nolan now holds 120,695 shares worth roughly $0.72 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Townsend Richard Nolan sold 5,000 shares, generating $40,496 in total proceeds. Upon selling the shares at $8.10, the Chief Executive Officer now owns 120,695 shares.
Before that, Townsend Richard Nolan sold 5,000 shares. Lexeo Therapeutics Inc shares valued at $53,274 were divested by the Chief Executive Officer at a price of $10.65 per share. As a result of the transaction, Townsend Richard Nolan now holds 120,695 shares, worth roughly $0.72 million.
Robert W. Baird initiated its Lexeo Therapeutics Inc [LXEO] rating to an Outperform in a research note published on June 13, 2024; the price target was $28. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Stifel began covering LXEO with “Buy” recommendation on November 28, 2023. RBC Capital Mkts started covering the stock on November 28, 2023. It rated LXEO as “an Outperform”.
Price Performance Review of LXEO
On Monday, Lexeo Therapeutics Inc [NASDAQ:LXEO] saw its stock fall -9.77% to $6.00. Over the last five days, the stock has lost -24.53%. Lexeo Therapeutics Inc shares have fallen nearly -55.29% since the year began. Nevertheless, the stocks have fallen -45.90% over the past one year. While a 52-week high of $22.33 was reached on 01/18/24, a 52-week low of $6.65 was recorded on 11/18/24. SMA at 50 days reached $8.91, while 200 days put it at $12.83.
Levels Of Support And Resistance For LXEO Stock
The 24-hour chart illustrates a support level at 5.66, which if violated will result in even more drops to 5.33. On the upside, there is a resistance level at 6.48. A further resistance level may holdings at 6.96. The Relative Strength Index (RSI) on the 14-day chart is 27.26, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.92, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.79%. Stochastics %K at 4.84% indicates the stock is a buying.
How much short interest is there in Lexeo Therapeutics Inc?
A steep rise in short interest was recorded in Lexeo Therapeutics Inc stocks on 2024-10-31, growing by 0.12 million shares to a total of 2.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 2.07 million shares. There was a rise of 5.51%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 28, 2023 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $19 price target.
